calidibio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: | ||
Meta Tags
| Title | Calidi Biotherapeutics - Pioneering cancer treatment options of the |
| Description | To Eradicate Cancer with Allogeneic Cell-Based Oncolytic We’re on a Mission to Find The Cure For Cancer By Delivering Oncolytic Viruses That Are Designed To Attack |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.199.119.98 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
calidibio.com Valuation
|
US$6,895,006
Last updated: 2023-05-09 06:49:11
calidibio.com has Semrush global rank of 1,535,068. calidibio.com has an estimated worth of US$ 6,895,006, based on its estimated Ads revenue. calidibio.com receives approximately 795,578 unique visitors each day. Its web server is located in United States, with IP address 104.199.119.98. According to SiteAdvisor, calidibio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,895,006 |
| Daily Ads Revenue | US$6,365 |
| Monthly Ads Revenue | US$190,939 |
| Yearly Ads Revenue | US$2,291,264 |
| Daily Unique Visitors | 53,039 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| calidibio.com. | A | 600 | IP: 104.199.119.98 |
| calidibio.com. | NS | 3600 | NS Record: ns33.domaincontrol.com. |
| calidibio.com. | NS | 3600 | NS Record: ns34.domaincontrol.com. |
| calidibio.com. | MX | 3600 | MX Record: 0 calidibio-com.mail.protection.outlook.com. |
| calidibio.com. | TXT | 3600 | TXT Record: MS=ms34796364 |
| calidibio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-09 06:49:11
| Company Our Team Advisory Board Board of Directors Careers Science Our Technologies Our Pipeline Treating Covid-19 Press Publications Contact Home our Company Our Team Advisory Board Board of Directors Our Science Treating Covid-19 Our Technologies Our Pipeline In The News Contact Our Mission To Eradicate Cancer with Allogeneic Cell-Based Oncolytic Platforms Learn More Our “off-the-shelf” supply of mesenchymal stem cells (MSCs) have been used for viral therapy applications outside of cancer treatment. Our Technology Calidi’s years of research into the powerful therapeutic effects of stem cells have revealed exciting and groundbreaking implications for the treatment of cancer and other therapy-resistant diseases. Pre-clinical data has shown our SNV1 product to shield the oncolytic virus from a patient’s immune system, supporting efficient delivery to tumor sites and effectively potentiating the viral payload. Learn More Our Team A talented, seasoned group of world-class executives, |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 31 Oct 2021 10:29:55 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Keep-Alive: timeout=20 Location: https://calidibio.com/ HTTP/2 200 server: nginx date: Sun, 31 Oct 2021 10:29:55 GMT content-type: text/html; charset=UTF-8 content-length: 19019 vary: Accept-Encoding vary: Accept-Encoding expires: Thu, 19 Nov 1981 08:52:00 GMT pragma: no-cache x-powered-by: WP Engine x-cacheable: SHORT vary: Accept-Encoding,Cookie cache-control: max-age=600, must-revalidate x-cache: HIT: 1 x-cache-group: normal accept-ranges: bytes |
calidibio.com Whois Information
Domain Name: CALIDIBIO.COM Registry Domain ID: 2260130638_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-05T12:07:21Z Creation Date: 2018-05-04T20:19:17Z Registry Expiry Date: 2022-05-04T20:19:17Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: ok https://icann.org/epp#ok Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T20:26:44Z <<< |